The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.

Nat Commun · 2023 · PMC10359414 · PMID 37474499

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significancep = 0.07so close (0.05 < p ≤ 0.1)

The rate of KRAS amplification increased from 3.3% (4/122) at diagnosis to 9.4% (12/127) at relapse, although this did not reach statistical significance ( p = 0.07; Fisher’s exact test) (Fig. 3B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.